drugset / Trial / NCT00003424

Tamoxifen in Treating Patients With Primary Liver Cancer

NCT00003424

RandomizedTreatment

Summary

RATIONALE: Estrogen can stimulate the growth of cancer cells. Hormone therapy using tamoxifen may fight liver cancer by blocking the absorption of estrogen. It is not yet known whether receiving tamoxifen is more effective than no further therapy in treating patients with primary liver cancer. PURPOSE: Randomized phase III trial to compare high-dose tamoxifen with no further treatment in treating patients with liver cancer that cannot be surgically removed.

Timeline

Start
1997-04
Primary completion
2000-06
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Tamoxifen Small molecule Oral

Indications